February 2017 - Bretton Fund

Fund
- Fund Details
- Investment Process
About Us
News
Invest

Month: February 2017

February 21, 2017

2016 Annual Report to Shareholders

This shareholder letter is part of the Bretton Fund 2016 Annual Report (pdf). February 17, 2017 Dear Fellow Shareholders: The Bretton Fund’s net asset value per share (NAV) as of December 31, 2016,…

Newsletter

Sign up for the shareholder letters.

Leave this field empty if you're human:

CATEGORIES

Letters
News
Media

ARCHIVES

Need to reach us? Call or email us.

The fund's investment objectives, risks, charges and expenses must be considered carefully before investing. The prospectus contains this and other important information about the investment company, and it may be obtained here or by calling 800.231.2901. Read it carefully before investing. An investment in the fund is subject to investment risks, including the possible loss of the principal amount invested. There can be no assurance that the fund will be successful in meeting its objectives. The fund invests in common stocks which subjects investors to market risk. The fund invests in small and micro-cap companies, which involve additional risks such as limited liquidity and greater volatility. The fund invests in undervalued securities. Undervalued securities are, by definition, out of favor with investors, and there is no way to predict when, if ever, the securities may return to favor. The fund invests in foreign securities which involve greater volatility and political, economic and currency risks and differences in accounting methods. Investments in debt securities typically decrease in value when interest rates rise. This risk is usually greater for longer-term debt securities. More information about these risks and other risks can be found in the fund’s prospectus. The fund is a nondiversified fund and therefore may be subject to greater volatility than a more diversified investment. Distributed by Arbor Court Capital, LLC - Member FINRA / SIPC

© 2023 Bretton Capital Management. All rights reserved.

Privacy Preference Center

Privacy Preferences